Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study-Reference-Cited by-同舟云学术

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study

Published:2022-11 Issue:11 Volume:3 Page:100785
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Hu Jiao,Chen Jinbo,Ou Zhenyu,Chen Haige,Liu Zheng,Chen Minfeng,Zhang Ruiyun,Yu Anze,Cao Rui,Zhang Enchong,Guo Xi,Peng Bo,Deng Dingshan,Cheng Chunliang,Liu Jinhui,Li Huihuang,Zou Yihua,Deng Ruoping,Qin Gang,Li Wenze,Wang Lue,Chen Tao,Pei Xiaming,Gong Guanghui,Tang Jiansheng,Othmane Belaydi,Cai Zhiyong,Zhang Chunyu,Liu Zhi,Zu Xiongbing^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;Griffiths;J. Clin. Oncol.,2011

2. Four versus 3 cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: implications for pathological response and survival;Patel;J. Urol.,2022

3. Identifying the optimal number of neoadjuvant chemotherapy cycles in patients with muscle invasive bladder cancer;D'Andrea;J. Urol.,2022

4. Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire;Burger;Eur. Urol.,2012

5. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer;Raj;Cancer,2011

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis;The French Journal of Urology;2024-09

2. Complete remission in a patient with sinonasal squamous cell carcinoma receiving neoadjuvant tislelizumab plus chemotherapy: a case report;Frontiers in Immunology;2024-07-15

3. Recent Advances of Neoadjuvant Immunotherapy for Urothelial Bladder Cancer;Annals of Surgical Oncology;2024-07-12

4. Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group;Frontiers in Oncology;2024-07-04

5. Securinine inhibits the tumor growth of human bladder cancer cells by suppressing Wnt/β-catenin signaling pathway and activating p38 and JNK signaling pathways;Biochemical Pharmacology;2024-05